08.09.19

FDA Does Not Approve Kala Pharmaceuticals’ NDA for Dry Eye Disease Candidate

Source: Kala Pharmaceuticals

08.07.19

TopiVert Announces Topline Results from Phase 2b/3 Study of Dry Eye Disease Drug Candidate

Source: TopiVert

07.24.19

Oyster Point Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease

Source: Oyster Point Pharma

07.22.19

Glaukos Announces Global Licensing Agreement With Intratus, Maker of Noninvasive Drug Delivery Platform

Source: Glaukos

06.27.19

NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System for Treating Dry Eye Disease

Source: NuSight Medical

06.25.19

Dompé Announces First Patient Enrolled in Phase 2b Clinical Trial Investigating Dry Eye Disease Drug Candidate

Source: Dompé

05.29.19

Quantel Medical Receives CE Mark for Dry Eye Treatment Platform Lacrystim IPL

Source: Quantel Medical

05.17.19

Neuropathy May Drive Dry Eye in Migraine Patients

Source: Reuters

05.14.19

Allegro Announces Positive Results of Ex-US Proof-of-Concept Trial With ALG-1007 for Dry Eye Disease

Source: Allegro Ophthalmics

05.13.19

ReGenTree Initiates ARISE-3 (Phase 3) Trial for Dry Eye Syndrome

Source: ReGenTree

View more stories